Author

Mario Q. Marcondes

Nektar Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew J. SnyderiD· 1 shared Dani Miller· 1 shared Ekram A. Gad· 1 shared Emma BinghamiD· 1 shared Kevin C. BarryiD· 1 shared Lillian LeBlanc· 1 shared Madeleine E. VolfbeyniD· 1 shared Mari Hoffman· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrew J. SnyderORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NKTR-255, a polymer-conjugated IL-15, synergizes with CAR-T cell therapy to activate endogenous anti-tumor immunity and improve tumor control

W. Sam Nutt, Mitchell G. Kluesner, Emma Bingham, Ekram A. Gad, Dani Miller, Victor Zepeda, Andrew J. Snyder, Sydney A. Marsh, Shannon M. Liudahl, Mari Hoffman, Lillian LeBlanc, Madeleine E. Volfbeyn, Sarah M. Garrison, Megha Sarvothama, Kevin C. Barry, , Shivani Srivastava

This study shows that combining NKTR-255 with CAR-T therapy enhances tumor control by boosting CAR-T function and endogenous anti-tumor immunity in solid tumors.

bioRxiv · Dec 15, 2025 · PreprintImmunology